BRPI0821105A2 - ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular - Google Patents

ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular

Info

Publication number
BRPI0821105A2
BRPI0821105A2 BRPI0821105A BRPI0821105A BRPI0821105A2 BR PI0821105 A2 BRPI0821105 A2 BR PI0821105A2 BR PI0821105 A BRPI0821105 A BR PI0821105A BR PI0821105 A BRPI0821105 A BR PI0821105A BR PI0821105 A2 BRPI0821105 A2 BR PI0821105A2
Authority
BR
Brazil
Prior art keywords
diseases
therapeutic
diagnostic tools
vascular function
alter vascular
Prior art date
Application number
BRPI0821105A
Other languages
English (en)
Inventor
Erik Sjoerd Gerard Stroes
Hans Vink
Original Assignee
Academisch Ziekenhuis Maastricht
Univ Maastricht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39247715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0821105(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Academisch Ziekenhuis Maastricht, Univ Maastricht filed Critical Academisch Ziekenhuis Maastricht
Publication of BRPI0821105A2 publication Critical patent/BRPI0821105A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/328—Vasculitis, i.e. inflammation of blood vessels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0821105A 2007-11-30 2008-12-01 ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular BRPI0821105A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122043 2007-11-30
PCT/EP2008/066524 WO2009068685A1 (en) 2007-11-30 2008-12-01 Diagnostic and therapeutic tools for diseases altering vascular function

Publications (1)

Publication Number Publication Date
BRPI0821105A2 true BRPI0821105A2 (pt) 2015-10-06

Family

ID=39247715

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821105A BRPI0821105A2 (pt) 2007-11-30 2008-12-01 ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular

Country Status (12)

Country Link
US (1) US8759095B2 (pt)
EP (1) EP2215480B1 (pt)
JP (1) JP5597543B2 (pt)
CN (1) CN101918845B (pt)
AT (1) ATE554396T1 (pt)
BR (1) BRPI0821105A2 (pt)
CA (1) CA2706307C (pt)
DK (1) DK2215480T3 (pt)
ES (1) ES2386231T3 (pt)
PL (1) PL2215480T3 (pt)
PT (1) PT2215480E (pt)
WO (1) WO2009068685A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5597543B2 (ja) 2007-11-30 2014-10-01 ユニフェルシテイト マーストリヒト 糖衣の幅を決定する方法およびプログラム
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
US10070796B2 (en) 2015-02-04 2018-09-11 General Electric Company Systems and methods for quantitative microcirculation state monitoring
WO2016164787A2 (en) 2015-04-08 2016-10-13 Microvascular Health Solutions, LLC Synergistic glycocalyx treatment compositions and methods
WO2016176089A1 (en) 2015-04-29 2016-11-03 Kardiatonos, Inc. Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
US10507252B2 (en) 2016-03-17 2019-12-17 Paul C. Lee Nanoparticle probes and methods of making and use thereof
US10507253B2 (en) 2016-03-17 2019-12-17 Paul C. Lee Nanoparticle probes and methods of making and use thereof
WO2018208846A1 (en) * 2017-05-08 2018-11-15 Microvascular Health Solutions, LLC Compositions, systems, and methods for assessing and improving vascular health and treatments involving the same
CN107271348B (zh) * 2017-07-06 2019-11-15 苏州大学 一种医用人造管道渗透性能测试系统及其使用方法
EP4545968A3 (en) * 2017-12-13 2026-03-18 GLX Analytix ApS Biomarkers for multiple sclerosis
CN108681510A (zh) * 2018-05-21 2018-10-19 迈克医疗电子有限公司 数据处理方法及装置
EP3623816A1 (en) 2018-09-12 2020-03-18 GLX Analytix ApS Glx-derived molecule detection
CN111394245B (zh) * 2018-12-12 2024-05-14 中科芯瑞(苏州)生物科技有限公司 用于筛选对内皮糖萼相关疾病具有预防和治疗活性的化合物的方法和装置
US11852577B2 (en) * 2021-09-29 2023-12-26 Orange Biomed Ltd., Co. Apparatus for measuring properties of particles in a solution and related methods
JP2025540023A (ja) 2022-12-09 2025-12-11 オレンジ バイオメッド カンパニー リミテッド 赤血球の特性を測定するためのサンプル検査システム

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
JP3566756B2 (ja) 1993-09-03 2004-09-15 謙 石原 非侵襲血液分析装置とその方法
WO2001022741A2 (en) 1999-09-23 2001-03-29 Nadeau Richard G Medical applications of orthogonal polarization spectral imaging
EP1501566B1 (de) * 2002-05-09 2008-08-13 Hemoteq AG Hemokompatibel beschichtete medizinprodukte, deren herstellung und verwendung
CN101558992B (zh) 2003-09-02 2012-01-04 早出广司 葡萄糖传感器和葡萄糖浓度测定装置
US20070225579A1 (en) * 2004-05-14 2007-09-27 Koninklijke Philips Electronics, N.V. Fiber Optic Probe
JP2007054483A (ja) 2005-08-26 2007-03-08 Olympus Corp 装着型顕微鏡システム
WO2007075388A2 (en) 2005-12-15 2007-07-05 X-Cell Medical Incorporated Methods of locally treating and preventing cardiac disorders
JP5597543B2 (ja) 2007-11-30 2014-10-01 ユニフェルシテイト マーストリヒト 糖衣の幅を決定する方法およびプログラム

Also Published As

Publication number Publication date
DK2215480T3 (da) 2012-07-30
EP2215480B1 (en) 2012-04-18
CA2706307A1 (en) 2009-06-04
CN101918845B (zh) 2014-01-29
US20100304424A1 (en) 2010-12-02
EP2215480A1 (en) 2010-08-11
US8759095B2 (en) 2014-06-24
PL2215480T3 (pl) 2012-09-28
ES2386231T3 (es) 2012-08-14
PT2215480E (pt) 2012-07-18
JP2011507560A (ja) 2011-03-10
WO2009068685A1 (en) 2009-06-04
CA2706307C (en) 2017-01-17
JP5597543B2 (ja) 2014-10-01
CN101918845A (zh) 2010-12-15
ATE554396T1 (de) 2012-05-15

Similar Documents

Publication Publication Date Title
BRPI0821105A2 (pt) ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
CY1120434T1 (el) Πρωτεϊνες προσδεσης il-1
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
MX2013001362A (es) Inmunoglubinas de dominio variable doble y usos de las mismas.
MA32934B1 (fr) Combinaisons inhibitrices hsp90
ECSP10010580A (es) Inmunoglobulinas duales de dominio variable y sus aplicaciones
EA201101520A1 (ru) Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
BRPI0806941A2 (pt) Implementos de higiene bucal que têm elementos flexíveis, e métodos de produção dos mesmos
UY31562A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
GT201200109A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
GT200800123A (es) Compuestos mimeticos de lisina modificados
BRPI0923507A2 (pt) motor e dispositivo elétrico que usa o mesmo.
BRPI1008692A2 (pt) moléculas de anticorpos tendo especificidade para ox40 humano.
ECSP11011496A (es) Inmunoglobulinas de dominio variable dual y usos de las mismas
EP2153354A4 (en) FREE ENHANCED SEARCH PROCESSING VIA TEXT MESSAGE TRANSMISSION
BRPI0810185A2 (pt) Regulador de fluído e aparelho.
MA32349B1 (fr) Antagonistes de la voie hedgehog a base de phtalazines disubstituees
BRPI0719904A2 (pt) Aço inoxidável martensítico
CY1116802T1 (el) Ετεροκυκλικες ενωσεις
BR112012014669A2 (pt) componente para artigo de fumar, artigo de fumar e método
BRPI0906608A2 (pt) Métodos e composições para o tratamento de hemorragia subaracnóide aneurismal coronária e arterial.
FR2924118B1 (fr) Fragments d'anticorps inhibiteurs de la proteine nef du vih.
BRPI0814346A2 (pt) Uso de imidazoquinolinas para o tratamento de doenças dependentes de egfr ou doenças que adquiriram resistência a agentes que são direcionados aos membros da família de egfr.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL